OAC
ENZ

OMERS Administration Corp’s Enzo Biochem, Inc. ENZ Stock Holding History

OMERS Administration Corp’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-29,900
Closed -$103K – 116
2021
Q1 		$103K Buy
+29,900
New +$93K ﹤0.01% 337
2017
Q3 		– Sell
-14,000
Closed -$155K – 529
2017
Q2 		$155K Buy
+14,000
New +$130K ﹤0.01% 444

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OMERS Administration Corp's ENZ Position: Q2 2021 in Review

OMERS Administration Corp sold out of Enzo Biochem, Inc. (ENZ) in Q2 2021, closing a stake of 29,900 shares — an estimated $103K sold.

OMERS Administration Corp first reported a position in ENZ in Q2 2017 and held it in 2 quarters. The position peaked at $155K in Q2 2017. 72 funds tracked by Wall St. Rank hold ENZ as of Q2 2021.

  • OMERS Administration Corp reported no remaining Enzo Biochem, Inc. position as of Q2 2021 after selling out during the quarter.
  • OMERS Administration Corp sold 29,900 Enzo Biochem, Inc. shares in Q2 2021, an estimated $103K.
  • OMERS Administration Corp first reported a position in Enzo Biochem, Inc. in Q2 2017 and held it in 2 quarters.
  • OMERS Administration Corp's Enzo Biochem, Inc. position peaked at $155K in Q2 2017.
  • 72 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2021.

Based on OMERS Administration Corp's 13F filing for Q2 2021, filed 13 Aug 2021.